FACTORS AFFECTING OUTCOMES AFTER TRANSARTERIAL CHEMOEMBOLIZATION (TACE) FOR HEPATOCELLULAR CARCINOMA (HCC)

被引：0
|
作者：
Suman, A. [1 ,2 ]
Sharma, A. [1 ]
Venkataperumal, S. [2 ]
Limaye, A. [1 ,2 ]
Morelli, G. [1 ]
Clark, V. [1 ]
Soldevila-Pico, C. [1 ]
Cabrera, R. [1 ]
Firpi, R. [1 ]
Nelson, D. [1 ]
机构：
[1] Univ Florida, Gastroenterol Hepatol & Nutr, Gainesville, FL USA
[2] VA Med Ctr, Gainesville, FL USA
来源：
JOURNAL OF HEPATOLOGY | 2014年 / 60卷 / 01期
关键词：
D O I：
10.1016/S0168-8278(14)61119-3
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P959
引用
收藏
页码：S395 / S395
页数：1
相关论文
共 50 条
  • [1] Predictors of poor outcome for transarterial chemoembolization (TACE) in hepatocellular carcinoma (HCC).
    Prins, Petra
    Singh, Bhavana P.
    Armstrong, Samantha Ann
    He, Aiwu Ruth
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [2] The Role of Lipiodol in the Treatment of Hepatocellular Carcinoma (HCC) through Transarterial Chemoembolization (TACE)
    Popa, Bogdan Valeriu
    Bratu, Ana Magdalena
    Minoiu, Costin Aurelian
    Turculet, Claudiu
    Ene, Dragos
    Constantinescu, Gabriel
    Ilie, Madalina
    Popescu, Mina
    Badila, Elisabeta
    [J]. REVISTA DE CHIMIE, 2015, 66 (03): : 408 - 412
  • [3] Transarterial chemoembolization (TACE) for hepatocellular carcinoma (HCC): No need for antibiotic prophylaxis.
    Andriulli, A
    Modola, G
    Lezzi, G
    Siena, D
    Conoscitore, P
    Nardella, G
    Facciorusso, D
    Mangia, A
    Giacobbe, A
    [J]. GASTROENTEROLOGY, 1997, 112 (04) : A532 - A532
  • [4] Hepatocellular carcinoma (HCC): ART-score and retreatment with transarterial chemoembolization (TACE)
    Dionisio de Sousa, I. J.
    Rodrigues, J.
    Pais, A.
    Bonito, N.
    Jacinto, P.
    Marques, M.
    Ribeiro, J.
    Figueiredo, P.
    Gervasio, H.
    [J]. EUROPEAN JOURNAL OF CANCER, 2015, 51 : S420 - S421
  • [5] Trial Results for Sunitinib and Transarterial Chemoembolization (TACE) in Inoperable Hepatocellular Carcinoma (HCC)
    Wu, Y. V.
    Tomaszewski, G. M.
    Fetterly, G. J.
    Kuvshinoff, B.
    Groman, A.
    Wilkinson, N. W.
    Khushalani, N. I.
    Iyer, R. V.
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2012, 19 : S114 - S115
  • [6] Tumoral and angiogenesis factors in hepatocellular carcinoma (HCC) after drug eluting bead (DEB) transarterial chemoembolization (TACE) with doxorubicin
    Farris, A. B.
    Dhanasekaran, R.
    Dursun, N.
    Coban, I.
    McIntosh, E. B.
    Adsay, V.
    Kim, H. S.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [7] Thalidomide (Thal) tolerance in patients treated with transarterial chemoembolization (TACE) for hepatocellular carcinoma (HCC)
    Goldenberg, A
    Volm, M
    Hochster, H
    Muggia, F
    Rosen, R
    Teperman, L
    Morgan, G
    Schwartz, J
    Sung, M
    Wadler, S
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 376S - 376S
  • [8] Stereotactic body radiotherapy (SBRT) as an alternative to transarterial chemoembolization (TACE) for hepatocellular carcinoma (HCC)
    Sapir, Eli
    Tao, Yebin
    Parikh, Neehar D.
    Bazzi, Latifa
    Devlin, Pauline
    Novelli, Paula M.
    Cuneo, Kyle Clifford
    Lawrence, Theodore Steven
    Schipper, Matthew J.
    Feng, Mary
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [9] Transarterial Chemoembolization (TACE) of the hepatocellular carcinoma (HCC) in patients with portal vein thrombosis -: Experiences
    Herber, S.
    Pitton, M.
    Moench, C.
    Schneider, J.
    Manzl, N.
    Kummer, I.
    Kanzler, S.
    Schuchmann, M.
    Junginger, T.
    Dueber, C.
    Otto, G.
    [J]. ZENTRALBLATT FUR CHIRURGIE, 2007, 132 (04): : 306 - 315
  • [10] Transarterial chemoembolization (TACE) with doxorubicin eluting beads (DEB) for the treatment of hepatocellular carcinoma (HCC)
    Vit, A.
    De Pauli, F.
    Sponza, M.
    Mazzer, M.
    Foltran, L.
    Montanari, M.
    Piccoli, G.
    Fasola, G.
    Gasparini, D.
    Aprile, G.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
12345